Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Lipocine Inc. (NASDAQ: LPCN)
LPCN Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
59.90%
Analyst Rating:
HOLD
Analyst Forecast (1yr):
NOT AVAILABLE
LPCN Stock Analysis
LPCN
PE Ratio:
LPCN
PEG Ratio:
Not Available
LPCN
Forward EPS Growth (12 month):
0.00%
LPCN
PS Ratio:
6.3
LPCN
PSG Ratio:
0.1
LPCN
Forward Revenue Growth (12 month):
67.70%
LPCN Articles
No data was found